Log in to save to my catalogue

Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence

Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2303201644

Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence

About this item

Full title

Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence

Publisher

England: Future Medicine Ltd

Journal title

Future microbiology, 2019-10, Vol.14 (15), p.1261-1279

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

Malaria puts more than 3 billion people at risk of infection and causes high morbidity and mortality.
forms hypnozoites, which may initiate recurrences, even in the absence of reinfection or superinfection. Until recently, the only drug available for eliminating hypnozoites was primaquine (PQ), which, given its short half-life, requires a relati...

Alternative Titles

Full title

Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2303201644

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2303201644

Other Identifiers

ISSN

1746-0913

E-ISSN

1746-0921

DOI

10.2217/fmb-2019-0202

How to access this item